Research

Mixed

Persistent muscle weakness and atrophy in ICU survivors (6 months post-discharge) are driven by impaired muscle regrowth and decreased satellite cell content, rather than ongoing proteolysis, inflammation, or mitochondrial dysfunction.

For ICU survivors, visual muscle size is not a reliable indicator of functional recovery. If muscle size returns but strength does not, the issue is likely impaired contractile quality or lack of satellite cells, not ongoing muscle breakdown. Rehabilitation should focus on functional capacity and potentially regenerative strategies rather than just hypertrophy or anti-catabolic measures.

ModerateRefutesMEDIUM confidence
Long term weakness in ICU survivors results from heterogeneous muscle pathophysiology with variable combinations of muscle atrophy and impaired contractile capacity. These findings are not explained by ongoing muscle proteolysis, inflammation or diminished mitochondrial content. Sustained muscle atrophy is associated with decreased satellite cell content and compromised muscle regrowth, suggesting impaired regenerative capacity.
Claúdia C. dos Santos et al. · American Journal of Respiratory and Critical Care Medicine · 2016

Why this rating

Pilot study with small sample size (n=11 at 6 months) and lack of pre-admission baseline biopsies limits generalizability.

Source

Mechanisms of Chronic Muscle Wasting and Dysfunction after an Intensive Care Unit Stay. A Pilot Study

Claúdia C. dos Santos et al. · American Journal of Respiratory and Critical Care Medicine · 2016

DOI 10.1164/rccm.201512-2344oc

cohort · n=15Cited 273×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →